Ingestible Vital Signs Monitor Shows Promise in First-in-Human Trial
New device developed by a company founded by Brigham researchers detected an opioid-overdose in preclinical models and captured respiratory rates and heart rates in 10 patients with sleep apnea
Source: BWH News - Category: Hospital Management Source Type: news
More News: Cardiology | Heart | Hospital Management | Overdose | Respiratory Medicine | Sleep Apnea | Sleep Disorders | Sleep Medicine